Welty; Devin F.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Welty; Devin F..The latest application filed is for "ketorolac compositions for corneal wound healing".

Company Profile

1.7.23

Welty; Devin F. - Foothill Ranch CA
Welty; Devin F. - Watertown MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Ketorolac Compositions For Corneal Wound Healing App 20210315805 - Hollander; David A. ; et al.	2021-10-14
Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain App 20200197336 - Farnes; Eldon Quinn ; et al.	2020-06-25
Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain App 20160243078 - Farnes; Eldon Quinn ; et al.	2016-08-25
Ketorolac tromethamine compositions for treating or preventing ocular pain Grant 9,192,571 - Farnes , et al. November 24, 2	2015-11-24
Intraocular drug delivery systems Grant 8,969,415 - Robinson , et al. March 3, 2	2015-03-03
Intraocular Drug Delivery Systems App 20140341968 - Robinson; Michael R. ; et al.	2014-11-20
Method For Determining Optimum Intraocular Locations For Drug Delivery Systems App 20140010823 - Robinson; Michael R. ; et al.	2014-01-09
Method for determining optimum intraocular locations for drug delivery systems Grant 8,571,802 - Robinson , et al. October 29, 2	2013-10-29
Ketorolac Compositions For Corneal Wound Healing App 20130245088 - Hollander; David A. ; et al.	2013-09-19
Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain App 20130030032 - Farnes; Eldon Q. ; et al.	2013-01-31
Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain App 20120196914 - Farnes; Eldon Quinn ; et al.	2012-08-02
Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain App 20120196913 - Farnes; Eldon Q. ; et al.	2012-08-02
Ketorolac Compositions For Corneal Wound Healing App 20110275688 - HOLLANDER; David A. ; et al.	2011-11-10
Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain App 20110160271 - Farnes; Eldon Q. ; et al.	2011-06-30
Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain App 20110046198 - Farnes; Eldon Q. ; et al.	2011-02-24
Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain App 20110021595 - Farnes; Eldon Q. ; et al.	2011-01-27
Ketorolac tromethamine compositions for treating ocular pain Grant 7,842,714 - Farnes , et al. November 30, 2	2010-11-30
Methods And Compositions For The Treatment Of Conditions Related To Gastric Acid Secretion App 20100298205 - Shen; Jie ; et al.	2010-11-25
Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain App 20100087503 - Farnes; Eldon Q. ; et al.	2010-04-08
Ketorolac Tromethamine Compositions For Treating Or Preventing Ocular Pain App 20090326034 - Farnes; Eldon Q. ; et al.	2009-12-31
Methods and compositions for the treatment of conditions related to gastric acid secretion App 20090048302 - Shen; Jie ; et al.	2009-02-19
Method For Determining Optimum Intraocular Locations For Drug Delivery Implant App 20080181929 - Robinson; Michael R. ; et al.	2008-07-31
Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump ihhibitor prodrugs App 20060241037 - Olejnik; Orest ; et al.	2006-10-26
Methods for treating ocular conditions with cyclic lipid contraining microparticles App 20060182781 - Hughes; Patrick ; et al.	2006-08-17
Methods and compositions for the oral administration of prodrugs of proton pump inhibitors App 20050075371 - Shen, Jie ; et al.	2005-04-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.